Generali Investments CEE’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.85M Hold
52,948
0.23% 121
2026
Q1
$4.51M Hold
52,948
0.24% 122
2025
Q4
$4.18M Buy
52,948
+26,548
+101% +$2.08M 0.29% 111
2025
Q3
$2.11M Sell
26,400
-1,200
-4% -$102K 0.16% 169
2025
Q2
$2.51M Hold
27,600
0.21% 137
2025
Q1
$2.59M Buy
27,600
+3,000
+12% +$269K 0.24% 134
2024
Q4
$2.24M Buy
+24,600
New +$2.35M 0.23% 134

Other funds holding CL

Generali Investments CEE's CL Position: Q2 2026 in Review

Generali Investments CEE held its Colgate-Palmolive (CL) position steady in Q2 2026 at 52,948 shares worth $4.85M. The position accounts for 0.23% of the portfolio, ranked #121.

Generali Investments CEE first reported a position in CL in Q4 2024 and has held it in 7 quarters since. 840 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Generali Investments CEE held 52,948 shares of Colgate-Palmolive worth $4.85M as of Q2 2026.
  • Generali Investments CEE left its Colgate-Palmolive share count unchanged in Q2 2026.
  • Colgate-Palmolive made up 0.23% of Generali Investments CEE's portfolio in Q2 2026, its #121 holding.
  • Generali Investments CEE first reported a position in Colgate-Palmolive in Q4 2024 and has held it in 7 quarters since.
  • 840 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Generali Investments CEE's 13F filing for Q2 2026, filed 13 Jul 2026.